EUCTR2004-004819-29-IT进行中（未招募）不适用
se of Rituximab in the treatment of extensive chronic graft versus host disease after allogenic stem cells transplantation
IVERSITA' DEGLI STUDI DI UDINE0 个研究点目标入组 20 人开始时间: 2005年8月1日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
First line treatment with Rituximab asociated to CVP plus Interferon in Follicular Lymphoma. Phase II study.Asociación de Rituximab al esquema CVP + Interferón en el tratamiento de primera línea del linfoma folicular - R-CVP-IFEUCTR2005-004761-42-ESFundacion Leucemia y Linfoma
已完成
不适用
Rituximab treatment of cyclophosphamide-resistant patients with ANCA-associated vasculitisANCA-associated vasculitisJPRN-UMIN000000906Research Comittee of Intractable Vasculitis Syndrome of the Ministry of Health, Labor and Welfare of Japan15
尚未招募
不适用
Rituximab administration for chronic antibody-mediated rejection after kidney transplantatioAntibody-mediated rejection after kidney transplantationJPRN-UMIN000018567Department of Nephrology and Hypertension, Saitama Medical Center, Saitama Medical University1
进行中（未招募）
不适用
Rituximab-2cda + Rituximab maintenance in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma - NDEUCTR2010-018519-14-ITISTITUTO EUROPEO DI ONCOLOGIA
已完成
不适用
ncontrolled trial of Rituximab treatment on refractory or steroid dependent nephrotic syndrome in adult.refractory or steroid dependent nephrotic syndromeJPRN-UMIN000014355Saitama Medical University Department of Nephrology5